Skip to main content

Table 3 Hematologic toxicity

From: A multicenter, non-randomized, phase II study of docetaxel and carboplatin administered every 3 weeks as second line chemotherapy in patients with first relapse of platinum sensitive epithelial ovarian, peritoneal or fallopian tube cancer

 

Grade of toxicity (NCI-CTVAE grade v2.0)

1

2

3

4

n(%)

n(%)

n(%)

n(%)

Leucocytopenia

15(20)

27(36)

21(28)

3(4)

Neutropenia

3(4)

5(7)

20(27)

39(53)

Febrile neutropenia

0(0)

0(0)

12(16)

0(0)

Thrombocytopenia

4(5)

1(1)

0(0)

2(3)

Anemia

44(59)

20(27)

0(0)

0(0)

  1. NCI-CTCAE: National Institute Common Toxicity Criteria for Adverse Events.